Pharmacology of topical prostaglandin F2 α analogs and their place in the treatment of glaucoma in small animals.

Abstract

A distinguishing feature of the most common types of glaucoma is an increased intra-ocular pressure (IOP), which has a damaging effect on optic nerve axons, leading to the progressive loss of retinal ganglion cells. Therefore, IOP-lowering medications are the mainstay of glaucoma therapy. Topical prostaglandin F2 α analogs (PGAs) are a relatively new class of ocular hypotensive drugs, which have made a huge impact on the treatment of glaucoma in dogs. This study summarizes the current state of knowledge on the mechanism of action of these agents and their effect on IOP in dogs and cats. It also discusses potential harmful side effects of PGAs and presents contemporary opinions about their role and place in the medical management of glaucoma in small animals.

• Authors: T Maślanka
• Journal: Journal of veterinary pharmacology and therapeutics (J Vet Pharmacol Ther) Vol. 38 Issue 2 Pg. 105-12 (Apr 2015) ISSN: 1365-2885 [Electronic] England
• PMID: 25230091 (Publication Type: Journal Article, Review)
• Copyright: © 2014 John Wiley & Sons Ltd.

Chemical References

• Dinoprost

Topics

• Administration, Topical
• Animals
• Cat Diseases (drug therapy)
• Cats
• Dinoprost (administration & dosage, analogs & derivatives, therapeutic use)
• Dog Diseases (drug therapy)
• Dogs
• Glaucoma (drug therapy, veterinary)
• Intraocular Pressure